Japan Cancer Association

Japan Cancer Association
Name	Japan Cancer Association
Native name	日本癌学会
Founded	1941
Headquarters	Tokyo, Japan
Fields	Oncology, Cancer Research, Public Health
Leader title	President
Leader name	Tetsuo Noda

Japan Cancer Association is a professional society focused on oncology, cancer research, and cancer control. Founded in 1941, it brings together clinicians, basic scientists, epidemiologists, pathologists, and public health specialists to advance understanding of carcinogenesis, cancer prevention, and clinical care. The association organizes annual meetings, issues peer-reviewed journals, and administers awards to recognize contributions that span laboratory research to population-based studies.

History

The association traces roots to prewar scientific groups that intersected with institutions such as Tokyo Imperial University, Kyoto University, Osaka University, Keio University, and Hokkaido University. Early members included researchers affiliated with institutes like the Japanese Cancer Research Foundation and laboratories connected to the National Cancer Center Hospital and the Cancer Institute of the Japanese Foundation for Cancer Research. Postwar reconstruction linked the society with international organizations including the Union for International Cancer Control and collaborations with the World Health Organization and the International Agency for Research on Cancer. Over decades the association has responded to shifts in Japanese healthcare policy such as reforms involving the Ministry of Health, Labour and Welfare (Japan) and demographic changes in prefectures like Osaka Prefecture, Tokyo Metropolis, and Hokkaidō. Milestones included the launch of its flagship journal and the expansion of symposia that featured scientists from United States National Institutes of Health, Cambridge University, Harvard Medical School, and the Karolinska Institutet.

Organization and Leadership

Governance is carried out by an executive board and committees with representation from major research universities—Tohoku University, Nagoya University, Kumamoto University, Tohoku Medical and Pharmaceutical University—and national research centers such as the National Cancer Center, Japan and the Riken research institute. Past presidents have held dual roles at institutions like Kyushu University and The University of Tokyo Hospital. Committees cover areas including clinical oncology, molecular biology, cancer epidemiology, pathology, and translational medicine, liaising with professional bodies such as the Japanese Society of Medical Oncology and the Japanese Association for Cancer Research. Administrative offices are based in Tokyo, coordinating regional chapters in prefectures including Kanagawa Prefecture, Aichi Prefecture, and Fukuoka Prefecture.

Mission and Activities

The association’s mission emphasizes promotion of basic and clinical cancer research, dissemination of evidence-based interventions, and education of professionals. Activities include organizing continuing medical education with partners like the Japanese Society of Clinical Oncology, publishing policy statements that inform agencies such as the Ministry of Health, Labour and Welfare (Japan), and supporting population screening initiatives studied in collaborations with municipal health bureaus in cities such as Yokohama and Sapporo. Outreach programs engage with patient advocacy organizations including groups modeled after the American Cancer Society and with international consortia from institutions like the European Organisation for Research and Treatment of Cancer.

Research and Publications

The association publishes a peer-reviewed journal that features articles spanning molecular oncology, epidemiology, and clinical trials, and contributes to compendia alongside journals from Nature Publishing Group, The Lancet Oncology, and Cancer Research. It funds grants and awards to investigators from laboratories at Osaka University Graduate School of Medicine, Nagoya Medical Center, and the National Institute of Biomedical Innovation. Collaborative research projects have connected researchers at Seoul National University Hospital, Stanford University School of Medicine, Johns Hopkins University, and Institut Gustave Roussy on topics such as carcinogen exposure, genomic profiling, and immunotherapy trials. The association’s publications have cited landmark works by researchers associated with Nobel recognition at institutions like Karolinska Institutet and have contributed to guideline development used by clinical networks such as the Japanese Breast Cancer Society.

Conferences and Awards

Annual scientific meetings attract presenters from universities including University of California, San Francisco, Imperial College London, and Peking University Health Science Center, alongside domestic investigators from Tohoku Pharmaceutical University and Kobe University. Symposia feature sessions on translational science, precision oncology, and survivorship with invited speakers from the National Cancer Institute (US), the European Society for Medical Oncology, and the American Association for Cancer Research. Prestigious awards administered by the association recognize lifetime achievement, early-career innovation, and clinical excellence, and have been conferred upon researchers affiliated with centers such as Tokyo Medical and Dental University and the Osaka International Cancer Institute.

Membership and Partnerships

Membership includes clinicians, basic scientists, doctoral students, and allied health professionals from hospitals and universities across Japan and internationally, including members from Seoul National University, Australian National University, McGill University, and Peking Union Medical College Hospital. Formal partnerships exist with national entities such as the National Cancer Center, Japan and international partners like the Union for International Cancer Control, World Health Organization, and research networks involving NIH cooperative groups. The association also collaborates with industry partners including pharmaceutical units at Takeda Pharmaceutical Company and multinational research programs with firms having links to Roche and Pfizer.

Category:Medical associations based in Japan Category:Cancer organizations